Consumer
Philip Morris Faces Lawsuit Over Zyn Oral Nicotine Pouches
- Firm that challenged Altria over Juul seeks class-action case
- Zyn can cause cognitive harm, gum disease, suit claims
This article is for subscribers only.
The tobacco industry’s next big hope for a less-harmful nicotine product, the oral nicotine pouch, just received its first major legal challenge in a lawsuit that says Philip Morris International’s Zyn product is addictive and harmful to young people.
The lawsuit says that the pouches deliver more nicotine than cigarettes, and that Philip Morris benefits from “Zynfluencers” who promote the brand on social media, with an estimated 30,000 TikTok accounts that use the hashtag #Zyn.